Evidence map›Paper›PMID 36726572›Full record

ArticleFrontiers in microbiology2022

Genomic insights of

William Calero-Cáceres, Kerly Rodríguez, Anabell Medina, Jennifer Medina, Nimer Ortuño-Gutiérrez, Temmy Sunyoto, Cícero Armídio Gomes Dias, Carlos Bastidas-Caldes, Maria Soledad Ramírez, Anthony David Harries

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Co-Harboring of Beta-Lactamases andAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 6 countries.

William Calero-CáceresUTA RAM One Health, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Kerly RodríguezBacteriophage Research Association, Ambato, Ecuador.
Anabell MedinaUTA RAM One Health, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Jennifer MedinaUTA RAM One Health, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Nimer Ortuño-GutiérrezDamien Foundation, Brussels, Belgium.
Temmy SunyotoMSFOCB Luxembourg Operational Research (LuxOR) Unit, Luxembourg, Luxembourg.
Cícero Armídio Gomes DiasDepartment of Basic Health Sciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.
Carlos Bastidas-CaldesOne Health Research Group, Biotecnología, Facultad de Ingeniería y Ciencias Aplicadas (FICA), Universidad de las Américas (UDLA), Quito, Ecuador.
Maria Soledad RamírezDepartment of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA, United States.
Anthony David HarriesInternational Union Against Tuberculosis and Lung Disease, Paris, France.
Universidad Técnica de Ambato · ECCalifornia State University, Fullerton · USInternational Union Against Tuberculosis and Lung Disease · FRMédecins Sans Frontières · LUUniversidad de Las Américas · ECUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of the One Health concept in attempting to deal with the increasing levels of multidrug-resistant bacteria in both human and animal health is a challenge for the scientific community, policymakers, and the industry. The discovery of the plasmid-borne mobile colistin resistance (

Indexed as

antibiotic resistance genescolistin resistanceEscherichia colimcr-1One Healthwhole-genome sequencing

Identifiers

PMID36726572
PMCPMC9884825
OpenAlexW4316363353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.